drugset / Trial / NCT05378698
Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The clinical efficacy of tralokinumab has been demonstrated in the treatment of AD; its MOA however remains insufficiently understood. A better understanding of the mechanisms underlying the clinical effects of tralokinumab would be of great clinical benefit since it may ultimately help us to identify more precisely candidate patients who may benefit from a therapy with tralokinumab.
Timeline
- Start
- 2022-06-15
- Primary completion
- 2025-03-04
- Completion
- 2025-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tralokinumab | Monoclonal antibody | — | — |